Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of $0.22, $0.10 better than the analyst estimate of $0.12. Revenue for the quarter came in at $264.03 million versus the consensus estimate of $227.61 million.

For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• Cytek faces $56M damages award in Beckman Coulter patent case
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises